Cloning and expression of the <i>porA</i> gene of the <i>Neisseria meningitidis</i> strain B : 4 : P1.15 in <i>Escherichia coli</i>. Preliminary characterization of the recombinant polypeptide
Gerardo Guillén(Hunan City University), Luís Herrera(Orlando Health), Olivia Niebla(Centro de Ingeniería Genética y Biotecnología), Maité Delgado, A.M. Martin(Institut thématique Génétique, génomique et bioinformatique), Silvia A. González(Centro de Ingeniería Genética y Biotecnología), Alain Bolaño Alvarez(Research Centre in Biological Chemistry of Córdoba), Alexis Musacchio(Instituto Cajal), R. Silva(Centro de Ingeniería Genética y Biotecnología)
Cited by 3
Related Papers
Epidermal growth factor in clinical practice – a review of its biological actions, clinical indications and safety implications
|International Wound Journal|2009|167
A novel cancer vaccine composed of human-recombinant epidermal growth factor linked to a carrier protein: Report of a pilot clinical trial
|Annals of Oncology|1998|155
Glucose Toxic Effects on Granulation Tissue Productive Cells: The Diabetics’ Impaired Healing
|BioMed Research International|2012|153
Wound Chronicity, Impaired Immunity and Infection in Diabetic Patients
|MEDICC Review|2021|139
Insulin Resistance at the Crossroad of Alzheimer Disease Pathology: A Review
|Frontiers in Endocrinology|2020|134